Prognostic factors in localized Hodgkin's lymphoma: How to define intermediate/unfavourable disease?

被引：0
|
作者：
Gisselbrecht, C [1 ]
Mounier, N [1 ]
Casanovas, O [1 ]
Reman, O [1 ]
Sebban, C [1 ]
Divine, M [1 ]
Brice, P [1 ]
Briere, J [1 ]
Hennequin, C [1 ]
Feugier, P [1 ]
Ferme, C [1 ]
机构：
[1] Hop St Louis, Grp Etud Lymphomes Adulte, Paris, France
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3122
引用
收藏
页码：853A / 853A
页数：1
相关论文
共 50 条
  • [41] Hodgkin lymphoma: Prognostic factors and new response criteria
    Cerny, T.
    Hitz, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 115 - 116
  • [42] Prognostic factors and treatment outcome in primary progressive Hodgkin's lymphoma - A report from the German Hodgkin's Lymphoma Study Group.
    Josting, A
    Rueffer, U
    Franklin, J
    Sieber, M
    Diehl, V
    Engert, A
    BLOOD, 1999, 94 (10) : 514A - 514A
  • [43] Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: Tumor and microenvironment
    Hsi, Eric D.
    LEUKEMIA & LYMPHOMA, 2008, 49 (09) : 1668 - 1680
  • [44] Prognostic factors in elderly patients with classical Hodgkin Lymphoma
    Fehr, M.
    Gusewell, S.
    Aeppli, S.
    Moccia, A.
    Bargetzi, M.
    Caspar, C.
    Brulisauer, D. M. A.
    Ebnother, M.
    Fischer, N.
    Ghilardi, G.
    Krasniqui, F.
    Lang, N.
    Mey, U.
    Mingrone, W.
    Novak, U.
    Richter, P.
    Rutti, M.
    Schmidt, A.
    Stenner, F.
    Voegeli, M.
    Zander, T.
    Hitz, F.
    Templeton, A. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 88 - 88
  • [45] Evaluation of Hodgkin lymphoma cases and determination of prognostic factors
    Seker, Mesut
    Mengi, Alperen
    Bilici, Ahmet
    Ustaalioglu, Bala Basak
    Kefeli, Umut
    Ozseker, Naciye Isik
    Mayadagli, Alparslan
    Salepci, Taflan
    Gumus, Mahmut
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2011, 26 (03): : 108 - 114
  • [46] Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring
    Harabuchi, Y
    Tsubota, H
    Ohguro, S
    Himi, T
    Asakura, K
    Kataura, A
    Ohuchi, A
    Hareyama, M
    ACTA ONCOLOGICA, 1997, 36 (04) : 413 - 420
  • [47] LOCALIZED LYMPHOMA OF BONE - PROGNOSTIC FACTORS AND TREATMENT RECOMMENDATIONS
    RATHMELL, AJ
    GOSPODAROWICZ, MK
    SUTCLIFFE, SB
    CLARK, RM
    BRITISH JOURNAL OF CANCER, 1992, 66 (03) : 603 - 606
  • [48] Hodgkin’s disease: Prognostic factors and short-course regimens
    Bartlett N.L.
    Arackal S.M.
    Current Oncology Reports, 2000, 2 (2) : 163 - 171
  • [49] Prognostic factors in early-stage Hodgkin's disease - In reply
    Colonna, P
    Andrieu, JM
    Jais, JP
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 412 - 412
  • [50] Prognostic factors, treatment, and outcome in SLE patients with non-hodgkin's lymphoma
    Bernatsky, S. R.
    Gordon, C.
    Nived, O.
    Sturfelt, G.
    Bae, S.
    Gascoyne, R.
    Ramsey-Goldmans, R.
    Clarke, A. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 456 - 457
12345